Why gait speed belongs in a clinical assessment

Supervised walking and mobility assessment in a rehabilitation setting

MedMeters literature review prepared 31 October 2026. The year in the article heading refers to the original study publication, not an earlier MedMeters posting date.

34,485 peoplein a pooled analysis of nine cohorts · findings from external research

Clinical question

Does the speed at which older adults walk carry clinically relevant information beyond a standalone number?

Study design

The authors pooled individual participant data from nine cohort studies, covering 34,485 community-dwelling adults aged 65 years or older. Follow-up ranged from six to 21 years.

What the researchers found

Gait speed was associated with survival across the studies. The pooled hazard ratio for death was 0.88 per 0.1 m/s higher gait speed (95% CI 0.87–0.90). These were observational associations, not causal effects of changing walking speed.

Why this matters for MedMeters

This supports making gait-speed measurement a priority clinical endpoint in the MedMeters Mobility roadmap. Recording consistent protocols over time can help clinicians follow the patient’s functional status.

What this does not prove

The study did not test computer vision or MedMeters and cannot establish that changing gait speed causes longer survival. Gait speed must be interpreted in clinical context and does not independently predict an individual patient’s outcome.

Original peer-reviewed publication

Gait Speed and Survival in Older Adults
Studenski et al. · JAMA · 2011
DOI: 10.1001/jama.2010.1923

External scientific evidence summary. Not medical advice. MedMeters is a concept under development and has not been evaluated in these studies. Clinical claims, validation and regulatory status must be established separately.